share_log

HC Wainwright & Co. Maintains Buy on Kronos Bio, Lowers Price Target to $2.5

HC Wainwright & Co. Maintains Buy on Kronos Bio, Lowers Price Target to $2.5

HC Wainwright & Co.維持對Kronos Bio的買入,將目標價下調至2.5美元
Benzinga ·  2023/12/19 06:16

HC Wainwright & Co. analyst Robert Burns maintains Kronos Bio (NASDAQ:KRON) with a Buy and lowers the price target from $9 to $2.5.

HC Wainwright & Co. 分析師羅伯特·伯恩斯維持Kronos Bio(納斯達克股票代碼:KRON)的買入並將目標股價從9美元下調至2.5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論